Navigation Links
ThromboGenics Announces Promising Results of MITI IV Phase II Trial in the Treatment of Acute Stroke with Microplasmin
Date:9/28/2008

scular blockages, 33% of patients treated with microplasmin achieved reperfusion compared with 14% of placebo-treated patients. Due to the small number of patients in this study, neither of these end points were statistically significant. However, the study also showed that microplasmin-treated patients had a statistically significant improvement in the level of damage to the blood brain barrier compared to placebo-treated patients, measured using the marker of matrix metalloproteinase (MMP). MMP activation plays a crucial role in the pathogenesis of brain edema and hemorrhagic transformation after ischemic stroke.

Professor Vincent Thijs, Lead Principal Investigator of the trial, commenting on the results said, "I am delighted that we were able to present these interesting results at the World Stroke Congress. The results show that microplasmin is safe and generally well tolerated with no evidence of increased bleeding risk. Moreover, the results also support previous preclinical studies that have shown that microplasmin is able to lyse clots and may also have certain vascular protective properties."

Dr. Patrik De Haes, CEO of ThromboGenics, commenting on today's announcement said: "I am very pleased that we have been able to successfully conclude this study of microplasmin in patients with stroke. The results that have been reported show that the product is well tolerated and could potentially be of benefit in this indication of high medical need. However, as we have stated previously, our current view is that it only makes sense for ThromboGenics to move forward with the development of microplasmin for vascular indications in cooperation with a partner, given the costs and risks involved. We believe that by focusing on the development of microplasmin for eye disease, where we have already generated encouraging clinical data, and carefully utilizing our resources on the other opportunities in our pipeline, we will continue to generate a high return f
'/>"/>

SOURCE ThromboGenics NV
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. ThromboGenics Completes Patient Enrolment in the Phase IIb Trial of Microplasmin in Vitrectomy (MIVI III)
2. Indevus Announces Agreement With Teva to Develop Pagoclone for the Treatment of Stuttering
3. Clinton Global Initiative Announces BDs Commitment to Biamba Marie Mutombo Hospital
4. Quark Pharmaceuticals Announces First RNAi Drug Candidate Having a Novel, Proprietary Structure Covered by Quark Intellectual Property
5. Chemstar Corporation Announces a New Powerful, One-Step Product That Effectively Controls Listeria, Salmonella, E. coli and Fly Larvae in Floor Drains
6. QuatRx Pharmaceuticals Announces Additional Data From Phase 3 Study for Ophena(TM) (Ospemifene Tablets) Showing Improvements in Clinical Symptoms of Vulvovaginal Atrophy
7. Anadys Pharmaceuticals Announces Successful Outcome of ANA598 Healthy Volunteer Study and Finalization of Study Design for Phase Ib Trial in HCV Patients
8. Phosphagenics Announces Initiation of Phase 1 Clinical Trial in Humans for Its Transdermal Lidocaine
9. Napo Announces Positive Clinical Data Indicating Crofelemer, Could Effectively Treat Cholera
10. Encorium Announces the Initiation of a Strategic Partnership With Prologue Research After the Postponement of Negotiations Regarding Its Planned Acquisition; Strategic Reorganization and Cost Reduction Plan Initiated as Strategic Alternatives are Investig
11. PEAK Surgical Announces Positive Results From Preclinical Study of PEAK PlasmaBlade(TM) Needle
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... and FT LAUDERDALE, Florida , ... ("OrbusNeich"), a designer, developer, manufacturer and marketer of innovative medical ... on May 13, 2015, it prevailed in a final opposition ... Patent EP 1 341 482 - STENT HAVING HELICAL ELEMENTS ... review in the EPO and has been upheld as a ...
(Date:7/1/2015)... SAN DIEGO , July 1, 2015  MEI Pharma, ... the clinical development of novel therapies for cancer, announced today ... Executive Officer, will present at the inaugural Cantor Fitzgerald Healthcare ... time from Le Parker Meridien in ... can be accessed at www.meipharma.com . A replay will ...
(Date:7/1/2015)... Lupin , ... Number of MPP Sub-licensees to Fourteen Companies   ... the rapid expansion of its network of generic manufacturers to ... develop MPP-licensed antiretrovirals (ARVs). New companies Lupin and Strides Arcolab ... HIV medicine the MPP licensed from ViiV Healthcare two months ...
Breaking Medicine Technology:OrbusNeich Announces Favorable Ruling from the European Patent Office and Initiation of Litigation Against Terumo Corporation 2MEI Pharma to Present at Cantor Fitzgerald Healthcare Conference 2The Medicines Patent Pool Increases its Generic Manufacturing Network to Ramp-Up Production of Low Cost Antiretrovirals (ARVs) 2The Medicines Patent Pool Increases its Generic Manufacturing Network to Ramp-Up Production of Low Cost Antiretrovirals (ARVs) 3
(Date:7/2/2015)... ... 02, 2015 , ... Maddock Douglas is an internationally recognized ... To help manage the increasing demand for innovation as a primary growth strategy, ... Strategic Engagements. , Benkendorf is a seasoned management executive with more than 25 ...
(Date:7/1/2015)... ... 01, 2015 , ... Sir Fazle Hasan Abed, BRAC’s founder and chairperson, was ... has been recognised for his outstanding contribution to enhancing the world's production and distribution ... the World Food Prize Foundation, announced this year’s winner at a ceremony at the ...
(Date:7/1/2015)... ... July 01, 2015 , ... ... term care, specialty, combo, and compounding pharmacy operations, announces the most recent positioning ... Cardinal Health RBC event at the Venetian Las Vegas, Nevada. ...
(Date:7/1/2015)... ... July 01, 2015 , ... The Collaborative for Children and Families (CCF) ... The grant will allow CCF to improve quality of care and save costs for ... to respond to many changes in New York’s Medicaid system. Experts agree that children ...
(Date:7/1/2015)... , ... July 01, 2015 , ... Did you know ... is Men’s Health Month, and we at Advanced Fertility Center of Texas (AFCT) would ... men. , While infertility is often considered to be a “woman’s issue,” male ...
Breaking Medicine News(10 mins):Health News:Business Builder Mark Benkendorf Joins Innovation Firm Maddock Douglas 2Health News:Sir Fazle Hasan Abed Receives World Food Prize 2Health News:Sir Fazle Hasan Abed Receives World Food Prize 3Health News:Pharmacy Software Vendor, SuiteRx IPS, Officially Introducing Newly Appointed CEO at Cardinal Health Event in Las Vegas, Nevada 2Health News:Pharmacy Software Vendor, SuiteRx IPS, Officially Introducing Newly Appointed CEO at Cardinal Health Event in Las Vegas, Nevada 3Health News:Pharmacy Software Vendor, SuiteRx IPS, Officially Introducing Newly Appointed CEO at Cardinal Health Event in Las Vegas, Nevada 4Health News:The Collaborative for Children and Families Receives a Grant From The New York Community Trust to Build Capacity for Comprehensive Child Welfare 2Health News:The Collaborative for Children and Families Receives a Grant From The New York Community Trust to Build Capacity for Comprehensive Child Welfare 3Health News:Male Fertility: Improve Testosterone and Fertility With Natural Approaches 2Health News:Male Fertility: Improve Testosterone and Fertility With Natural Approaches 3Health News:Male Fertility: Improve Testosterone and Fertility With Natural Approaches 4
... more than just faithful companionship: A new study led by ... walked their dogs were 34 percent more likely to meet ... Mathew Reeves, show that promoting dog ownership and dog walking ... meet recommended levels of leisure-time physical activity become healthier. ...
... In an effort to improve treatment and one ... Foundation today joined with key donors and community leaders ... of globalCure is an alliance between TGen and the ... cancer scientists, physicians and researchers, armed with the most ...
... , WEDNESDAY, March 9 (HealthDay News) -- The U.S. ... new treatment option in more than 50 years when it approved ... debilitating autoimmune disorder. Injected directly into a vein, Benlysta is ... the number of abnormal B cells believed to be at the ...
... Two studies published by an interdisciplinary team of Hong ... Cell Transplantation (20:1), now freely available on-line at ... adult brain cells (neurogenesis) in two critical areas of ... a stress reducer and also to sexual behavior and ...
... , THURSDAY, March 10 (HealthDay News) -- ... bones that surgeons should adjust for when they perform ... researchers. Previous studies have found that cerebral palsy ... the hips, but this is the first study to ...
... By Randy Dotinga HealthDay Reporter , WEDNESDAY, March ... diabetes were able to get injections of a new insulin drug ... findings still need to be confirmed in another phase of research, ... it were approved for this use. But those caveats aside, ...
Cached Medicine News:Health News:Grab the leash: Dog walkers more likely to reach exercise benchmarks 2Health News:TGen Foundation launches 'globalCure,' targets pancreatic cancer 2Health News:FDA Approves 1st New Lupus Drug in More Than 50 Years 2Health News:Brain cell regrowth linked to benefits of exercise, sexual behaviors and reproductive issues 2Health News:Brain cell regrowth linked to benefits of exercise, sexual behaviors and reproductive issues 3Health News:New Drug May Trim Insulin Injections to Just 3 a Week 2
The seed alignment tray aligns seeds and spacers for easy access to be picked up by the SeedVac™. It also interfaces with the seed sterilization and sorting tray for protection from radiation....
MT-BT-5011-25 Prostate seeding needle (set of 25 unloaded needles).,MT-BT-5011-P Prostate seeding needle, pre-plugged and pre-sterilized, unloaded or for use with MEDTECs ASAP™ pre-load seedin...
... ACMI™ offers five classes of ... vaporization, cutting loops, knife, roller bar ... are the only electrodes specifically integrated ... surgical tissue removal with minimal bleeding, ...
... Nephroscope, with a stainless steel shaft, combines ... lumbotome, for precise pre-cutting of scar tissue, ... access. The 13.5 Fr. oval working channel ... and lithotripsy probes, and allows a high ...
Medicine Products: